-
2'3'-cGAMP (Sodium Salt) in STING Research
2026-08-24
2'3'-cGAMP is an endogenous cGAS-derived second messenger that activates STING, TBK1, IRF3, and type I interferon induction. The 2'3'-cGAMP (sodium salt) product B8362 provides a defined research reagent for dissecting cGAS-STING signaling, with supplier-listed high-affinity STING binding and water-based formulation guidance.
-
Cisapride in Reliable Cell Assays
2026-08-23
Learn how Cisapride (SKU B1198) can serve as a mechanistic probe and reference compound in viability, proliferation, and cardiotoxicity workflows. This scenario-based guide connects formulation control, hERG biology, 5-HT4 signaling, and high-content phenotyping to more interpretable laboratory data.
-
Sulfur Supply Delays Soybean Nodule Senescence
2026-08-22
The reference study identifies sulfur delivery to the symbiosome as a regulatory checkpoint in soybean nodule longevity. By linking SULTR2;1 and SULTR3;5 activity with glutathione maintenance, reactive nitrogen species scavenging, and high-nitrogen stress, it provides a mechanistic framework for preserving symbiotic nitrogen fixation.
-
Fluorescein Tyramide for Sensitive TSA Detection
2026-08-22
Fluorescein Tyramide is a fluorescent labeling dye for enzyme-mediated tyramide signal amplification in IHC, ISH, and selected flow cytometry workflows. K1084 supports localized detection of low-abundance targets, but assay specificity and enzyme compatibility still depend on the underlying protocol.
-
n-Dodecyl-β-D-maltoside for Integrin Cryo-EM
2026-08-21
DDM provides a gentle route to solubilize and stabilize full-length membrane proteins while preserving conformational diversity for cryo-EM, purification, and functional assays. This practical guide translates recent αvβ3 integrin structures into detergent-screening, sample-preparation, and troubleshooting decisions.
-
Grazoprevir hydrate: HCV Research Workflows
2026-08-20
Grazoprevir hydrate, also known as MK-5172 hydrate, supports genotype-aware HCV replication studies through highly potent NS3/4A protease inhibition. This guide converts its pharmacology into practical dose-response, combination, resistance, and troubleshooting workflows for translational laboratories.
-
TAI-1 and the Next Logic of Mitotic Targeting
2026-08-20
TAI-1 is a potent Hec1 inhibitor that connects mitotic control, apoptotic cell death induction, and translational oncology strategy. This thought-leadership analysis places its Hec1-Nek2 mechanism alongside emerging evidence on replication-transcription conflicts after WEE1 inhibition, while defining practical validation, biomarker, combination, and preclinical development priorities.
-
FPH1 (BRD-6125): A Smarter Liver Assay Strategy
2026-08-19
FPH1 (BRD-6125) can be evaluated more rigorously by separating hepatocyte expansion from functional maturation. This guide connects primary human hepatocyte culture, iPSC-derived hepatocyte assays, and light-controlled gene-expression concepts without overstating the current evidence.
-
Silymarin: Research Uses, Mechanisms, and Limits
2026-08-19
Silymarin is a polyphenolic milk thistle extract used as a reference preparation in oxidative stress, cancer, antiviral, and metabolic research. Its mixture composition, low water solubility, and assay-dependent activity require careful controls and should not be interpreted as proof of clinical efficacy.
-
Entecavir (BMS200475): HBV Evidence
2026-08-18
Entecavir, also known as BMS200475, is a selective HBV DNA polymerase inhibitor that suppresses reverse transcription and viral DNA synthesis. Its strong activity against wild-type HBV, activity against selected lamivudine-resistant variants, and low long-term resistance rate support chronic hepatitis B infection therapy when treatment is clinically indicated.
-
Bifendate (DDB): Applied Liver Research Workflows
2026-08-18
Bifendate (DDB) supports practical studies of hepatic lipid accumulation, autophagy, and injury through coordinated cell-based and animal workflows. This guide combines formulation controls, flux-aware assay design, translational safety checks, and troubleshooting for more reproducible liver research.
-
Adefovir Dipivoxil in Chronic Hepatitis B
2026-08-17
The reference review established adefovir dipivoxil as a clinically useful nucleotide analog for chronic hepatitis B, emphasizing activity against both wild-type and lamivudine-resistant HBV, durable suppression, and relatively low resistance. Its practical significance lies in connecting the adefovir DNA polymerase inhibition pathway with evidence from heterogeneous patient populations, including HBeAg-positive, HBeAg-negative, decompensated, and transplant-associated disease.
-
Hydroxychloroquine Sulfate Protocol Guide
2026-08-17
Hydroxychloroquine Sulfate (SKU B4874) provides an aqueous-compatible option for experimental autophagy pathway modulation and toll-like receptor 7/9 signaling studies in autoimmune disease research. It is best suited to short-term, water-based workflows and should not be selected for protocols requiring DMSO or ethanol solubility or long-term storage of prepared solutions.
-
Nelfinavir Mesylate: Reliable Cell Assays
2026-08-16
A scenario-based guide to using Nelfinavir Mesylate (SKU A3653) in HIV infection research, cell-viability studies, and ferroptosis-related workflows. It connects quantitative product data with practical controls for stock preparation, assay interpretation, and vendor selection.
-
Cisplatin (CDDP): From DNA Damage to Translation
2026-08-15
A translational framework for using Cisplatin and CDDP to connect DNA crosslinking, apoptosis, oxidative stress, xenograft response, and chemotherapy resistance studies with more decision-ready experimental strategies.